Predictors of early mortality in very elderly patients with bacteremia: a prospective multicenter cohort.

[1]  M. Rodríguez-Carballeira,et al.  [Bloodstream infection in the up to 80 year-old-patients]. , 2012, Revista clinica espanola.

[2]  M. Falagas,et al.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  A. Del Arco,et al.  Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based Analysis , 2011, Antimicrobial Agents and Chemotherapy.

[4]  J. Rodríguez-Baño,et al.  Epidemiology and clinical features of community‐acquired, healthcare‐associated and nosocomial bloodstream infections in tertiary‐care and community hospitals , 2010 .

[5]  L. Nicolle.  Urinary tract infections in the elderly. , 2009, Clinics in geriatric medicine.

[6]  J. Rhee,et al.  SCORING SYSTEMS FOR PREDICTION OF MORTALITY IN PATIENTS WITH INTENSIVE CARE UNIT-ACQUIRED SEPSIS: A COMPARISON OF THE PITT BACTEREMIA SCORE AND THE ACUTE PHYSIOLOGY AND CHRONIC HEALTH EVALUATION II SCORING SYSTEMS , 2009, Shock.

[7]  M. Nørgaard,et al.  Short‐Term Mortality in Relation to Age and Comorbidity in Older Adults with Community‐Acquired Bacteremia: A Population‐Based Cohort Study , 2008, Journal of the American Geriatrics Society.

[8]  Michael Y. Lin,et al.  Delay of Active Antimicrobial Therapy and Mortality among Patients with Bacteremia: Impact of Severe Neutropenia , 2008, Antimicrobial Agents and Chemotherapy.

[9]  A. Payeras,et al.  Bacteriemia en pacientes muy ancianos: factores de riesgo, características clínicas y mortalidad , 2007 .

[10]  E. Elm,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[11]  Erik von Elm,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2008, Journal of clinical epidemiology.

[12]  Matthias Egger,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies , 2007, PLoS medicine.

[13]  Á. Soriano,et al.  Epidemiology and outcome of primary community-acquired bacteremia in adult patients , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[14]  Chien-Chang Lee,et al.  Comparison of Clinical Manifestations and Outcome of Community-Acquired Bloodstream Infections Among the Oldest Old, Elderly, and Adult Patients , 2007, Medicine.

[15]  T. Blackmore,et al.  Bloodstream infections in a secondary and tertiary care hospital setting , 2006, Internal medicine journal.

[16]  E. Ely,et al.  Insights into severe sepsis in older patients: from epidemiology to evidence-based management. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  C. Sprung,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Intensive Care Medicine.

[18]  Daniel J Sexton,et al.  Health CareAssociated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired Infections , 2002, Annals of Internal Medicine.

[19]  T. Yoshikawa.  Antimicrobial Resistance and Aging: Beginning of the End of the Antibiotic Era? , 2002, Journal of the American Geriatrics Society.

[20]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[21]  R. Bonomo.  Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  T. Yoshikawa,et al.  Epidemiology and unique aspects of aging and infectious diseases. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  P. Reynoso,et al.  Nuevos tratamientos de la sepsis grave. Una encrucijada científica, económica y ética , 1999 .

[24]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[25]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[26]  A. Oliver,et al.  Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  R. Martín.  Procedimientos en microbiologia clinica , 2009 .

[28]  E. Calbo,et al.  Bloodstream infections in adults: importance of healthcare-associated infections. , 2008, The Journal of infection.

[29]  G. Lebuffe,et al.  Nuevos tratamientos de la sepsis grave , 2006 .

[30]  M J Ferraro.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .

[31]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.